These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients. Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627 [TBL] [Abstract][Full Text] [Related]
4. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database. Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870 [TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors in ovarian germ cell malignancies. Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426 [TBL] [Abstract][Full Text] [Related]
6. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series]. Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011 [TBL] [Abstract][Full Text] [Related]
7. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy. Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194 [TBL] [Abstract][Full Text] [Related]
8. Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management. Liu YL; Manning-Geist BL; Knezevic A; Deng L; Bromberg M; Funt SA; Meisel JL; Zivanovic O; Roche KL; Sonoda Y; Gardner GJ; Grisham RN; O'Cearbhaill RE; Tew WP; Abu-Rustum NR; Chi DS; Aghajanian C; Feldman DR Gynecol Oncol; 2023 Mar; 170():93-101. PubMed ID: 36669327 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features. De Giorgi U; Rosti G; Salvioni R; Papiani G; Ballardini M; Pizzocaro G; Marangolo M Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152 [TBL] [Abstract][Full Text] [Related]
10. Optimal treatment strategy for intracranial germ cell tumors: a single institution analysis. Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Ariga H; Takai Y; Tominaga T J Neurosurg Pediatr; 2009 Dec; 4(6):506-14. PubMed ID: 19951035 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Li J; Yang W; Wu X Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461 [TBL] [Abstract][Full Text] [Related]
12. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery. Yang ZJ; Liu ZC; Wei RJ; Li L Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958 [TBL] [Abstract][Full Text] [Related]